Nicole Moxon

Pembrolizumab (pembro) with paclitaxel (taxol) or capecitabine (cape) as early treatment of metastatic triple-negative breast cancer (mTNBC).

David B. Page, Brie Chun, Joanna Pucilowska et al. · Journal of Clinical Oncology · 2019 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +16

Safety and efficacy of pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC).

David B. Page, Isaac K Kim, Katherine Sanchez et al. · Journal of Clinical Oncology · 2018 · 14 citations

Medicine, Pharmacology, Pharmacotherapy +17

A Phase Ib Study of Preoperative, Locoregional IRX-2 Cytokine Immunotherapy to Prime Immune Responses in Patients with Early-Stage Breast Cancer

David B. Page, Joanna Pucilowska, Katherine Sanchez et al. · Clinical Cancer Research · 2019 · 12 citations · Full text

Life Sciences, Immunology, Oncology +17

Abstract P2-09-03: Updated efficacy of first or second-line pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC) and correlations with baseline lymphocyte and naïve CD4+ T-cell count

DB Page, Joanna Pucilowska, Laura Bennetts et al. · Cancer Research · 2019 · 11 citations

Medicine, Oncology, Pharmacology +17

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang et al. · Journal for ImmunoTherapy of Cancer · 2016 · 11 citations · Full text

Life Sciences, Immunology, Oncology +13